Arvee Laboratories (India) Ltd. (ARVEE.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In INR
Sector
Basic Materials
Industry
Chemicals - Specialty
Employees
65
First IPO Date
February 22, 2018
| Name | Title | Pay | Year Born |
| Shalin Bharatbhai Chokshi | Whole-Time Director | 0 | 1984 |
| Saurin Ajitbhai Gandhi | Chief Financial Officer & Additional Director | 0 | 1983 |
| Shalin Sudhakarbhai Patel | Chairman & MD | 0 | 1978 |
| Raina Singh Chauhan | Company Secretary & Compliance Officer | 0 | N/A |
Arvee Laboratories (India) Ltd., established in 2012 and headquartered in Ahmedabad, India, specializes in the production and distribution of various specialized chemicals throughout the country. The company's product line includes a range of polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate. Additionally, Arvee Laboratories manufactures intermediates critical for contrast media, supplying compounds like 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, dimethyl 5-aminoisophthalate, 3,5-dinitrobenzoic acid, and 3,5-diamino benzoic acid. The firm also provides drug intermediates, specifically 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4-amino pyridine, and 2-chloro-5-nitrobenzoic acid. Beyond its domestic sales, Arvee Laboratories actively exports its chemical products.